Drug Shortage Report for CEFTRIAXONE SODIUM FOR INJECTION BP

Last updated on 2023-07-11 History
Report ID 188239
Drug Identification Number 02250292
Brand name CEFTRIAXONE SODIUM FOR INJECTION BP
Common or Proper name CEFTRIAXONE SODIUM FOR INJECTION BP
Company Name PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) CEFTRIAXONE
Strength(s) 1G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 10 x 1g vial
ATC code J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-04-01
Estimated end date
Actual end date 2023-07-10
Shortage status Resolved
Updated date 2023-07-11
Company comments Product is discontinued.
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2023-07-11 French Compare
v5 2023-07-11 English Compare
v4 2023-04-02 English Compare
v3 2023-03-29 French Compare
v2 2023-03-29 English Compare
v1 2023-03-29 English Compare

Showing 1 to 6 of 6